2,622 Shares in Labcorp Holdings Inc. $LH Purchased by Jump Financial LLC

Key Points

• Jump Financial LLC acquired 2,622 shares of Labcorp Holdings Inc., valued at approximately $610,000, as reported in a 13F filing with the SEC.
• Labcorp's latest earnings report showed an EPS of $4.35, surpassing analysts' expectations, with revenue of $3.53 billion and a year-over-year revenue increase of 9.6%.
• The company announced a quarterly dividend of $0.72, set to be paid on September 11th, with an annualized yield of 1.0% and a dividend payout ratio of 31.79%.

Jump Financial LLC acquired a new position in shares of Labcorp Holdings Inc. (NYSE:LH - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,622 shares of the medical research company's stock, valued at approximately $610,000.

A number of other large investors have also added to or reduced their stakes in LH. Brighton Jones LLC purchased a new stake in Labcorp during the fourth quarter worth about $991,000. Aptus Capital Advisors LLC increased its holdings in Labcorp by 3.2% during the fourth quarter. Aptus Capital Advisors LLC now owns 1,981 shares of the medical research company's stock worth $454,000 after buying an additional 62 shares during the last quarter. BNP Paribas Financial Markets increased its holdings in Labcorp by 35.3% during the fourth quarter. BNP Paribas Financial Markets now owns 171,479 shares of the medical research company's stock worth $39,324,000 after buying an additional 44,702 shares during the last quarter. Banque Transatlantique SA purchased a new position in shares of Labcorp in the fourth quarter worth about $66,000. Finally, Brown Advisory Inc. increased its stake in shares of Labcorp by 6.3% in the fourth quarter. Brown Advisory Inc. now owns 63,967 shares of the medical research company's stock worth $14,669,000 after purchasing an additional 3,791 shares in the last quarter. Hedge funds and other institutional investors own 95.94% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on the stock. Evercore ISI lifted their target price on shares of Labcorp from $285.00 to $300.00 and gave the company an "outperform" rating in a research report on Friday, July 25th. Morgan Stanley boosted their price objective on shares of Labcorp from $283.00 to $306.00 and gave the stock an "overweight" rating in a report on Friday, July 25th. Barclays reaffirmed a "cautious" rating on shares of Labcorp in a research note on Wednesday, June 25th. Robert W. Baird set a $311.00 target price on shares of Labcorp in a research note on Monday, August 25th. Finally, HSBC downgraded shares of Labcorp from a "buy" rating to a "hold" rating and set a $260.00 price objective on the stock. in a research report on Thursday, July 10th. Nine investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $290.33.

Labcorp Stock Up 1.0%

Shares of Labcorp stock opened at $278.07 on Monday. The company has a current ratio of 1.50, a quick ratio of 1.32 and a debt-to-equity ratio of 0.61. The company's fifty day simple moving average is $262.75 and its two-hundred day simple moving average is $249.21. The company has a market cap of $23.11 billion, a P/E ratio of 30.69, a PEG ratio of 1.78 and a beta of 0.85. Labcorp Holdings Inc. has a 12-month low of $209.38 and a 12-month high of $283.47.

Labcorp (NYSE:LH - Get Free Report) last issued its quarterly earnings data on Thursday, July 24th. The medical research company reported $4.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.14 by $0.21. The business had revenue of $3.53 billion for the quarter, compared to the consensus estimate of $3.49 billion. Labcorp had a net margin of 5.66% and a return on equity of 15.45%. The company's quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.94 EPS. Labcorp has set its FY 2025 guidance at 16.050-16.500 EPS. Research analysts anticipate that Labcorp Holdings Inc. will post 16.01 EPS for the current year.

Labcorp Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 11th. Stockholders of record on Thursday, August 28th will be given a $0.72 dividend. The ex-dividend date of this dividend is Thursday, August 28th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 1.0%. Labcorp's dividend payout ratio is currently 31.79%.

Insider Transactions at Labcorp

In other news, Director Dwight Gary Gilliland sold 2,000 shares of the company's stock in a transaction dated Wednesday, July 30th. The shares were sold at an average price of $264.95, for a total value of $529,900.00. Following the sale, the director directly owned 6,656 shares of the company's stock, valued at $1,763,507.20. This represents a 23.11% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Adam H. Schechter sold 5,643 shares of the company's stock in a transaction dated Monday, August 11th. The stock was sold at an average price of $266.78, for a total transaction of $1,505,439.54. Following the completion of the sale, the chief executive officer directly owned 93,319 shares in the company, valued at $24,895,642.82. This represents a 5.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 18,046 shares of company stock worth $4,831,192. 0.84% of the stock is owned by insiders.

Labcorp Profile

Labcorp Holdings, Inc engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Labcorp Holdings Inc. (NYSE:LH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.